Lamb AD - Search Results

1

Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years.

Sathianathen NJ, Lamb AD, Lawrentschuk NL, Goad JR, Peters J, Costello AJ, Murphy DG, Moon DA. Sathianathen NJ, et al. Among authors: lamb ad. ANZ J Surg. 2018 Mar;88(3):E200-E203. doi: 10.1111/ans.14169. Epub 2017 Sep 18. ANZ J Surg. 2018. PMID: 28922689

2

Disrupting the Status Quo in Prostate Cancer Diagnosis.

Lamb AD, Zargar H, Murphy DG, Corcoran NM, Hovens CM. Lamb AD, et al. Eur Urol. 2017 Feb;71(2):193-194. doi: 10.1016/j.eururo.2016.08.018. Epub 2016 Aug 21. Eur Urol. 2017. PMID: 27554242 No abstract available.

3

Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis.

Zargar H, Lamb AD, Rocco B, Porpiglia F, Liatsikos E, Davis J, Coelho RF, Pow-Sang JM, Patel VR, Murphy DG. Zargar H, et al. Among authors: lamb ad. Minerva Urol Nefrol. 2017 Feb;69(1):26-37. doi: 10.23736/S0393-2249.16.02797-1. Epub 2016 Aug 31. Minerva Urol Nefrol. 2017. PMID: 27579821 Free article.

4

Updates of prostate cancer staging: Prostate-specific membrane antigen.

Sathianathen NJ, Lamb A, Nair R, Geurts N, Mitchell C, Lawrentschuk NL, Moon DA, Murphy DG. Sathianathen NJ, et al. Investig Clin Urol. 2016 Dec;57(Suppl 2):S147-S154. doi: 10.4111/icu.2016.57.S2.S147. Epub 2016 Nov 30. Investig Clin Urol. 2016. PMID: 27995218 Free PMC article. Review.

5

Re: Diagnostic Accuracy of Multi-parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study.

Kapoor J, Lamb AD, Murphy DG. Kapoor J, et al. Among authors: lamb ad. Eur Urol. 2017 Jul;72(1):151. doi: 10.1016/j.eururo.2017.02.014. Epub 2017 Feb 24. Eur Urol. 2017. PMID: 28238478 No abstract available.

6

Prostate-specific membrane antigen radioguided surgery: a promising utility.

Geurts N, Lamb AD, Lawrentschuk N, Murphy DG. Geurts N, et al. Among authors: lamb ad. BJU Int. 2017 Jul;120(1):5-6. doi: 10.1111/bju.13838. BJU Int. 2017. PMID: 28621060 Free article. No abstract available.

7

The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory.

Sathianathen NJ, Geurts N, Nair R, Lawrentschuk N, Murphy DG, Lamb AD. Sathianathen NJ, et al. Among authors: lamb ad. Future Oncol. 2017 Aug;13(20):1801-1807. doi: 10.2217/fon-2017-0074. Epub 2017 Aug 1. Future Oncol. 2017. PMID: 28762288 Review.

8

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.

Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Gupta S, Lamb AD, Dahm P. Sathianathen NJ, et al. Among authors: lamb ad. Cochrane Database Syst Rev. 2018 Oct 15;10(10):CD012816. doi: 10.1002/14651858.CD012816.pub2. Cochrane Database Syst Rev. 2018. PMID: 30320443 Free PMC article.

9

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.

Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Gupta S, Lamb AD, Dahm P. Sathianathen NJ, et al. Among authors: lamb ad. BJU Int. 2019 Sep;124(3):370-372. doi: 10.1111/bju.14711. Epub 2019 Mar 20. BJU Int. 2019. PMID: 30763461 Review.

10

Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score.

Sathianathen NJ, Lane R 3rd, Condon B, Murphy DG, Lawrentschuk N, Weight CJ, Lamb AD. Sathianathen NJ, et al. Among authors: lamb ad. Eur Urol Focus. 2020 May 15;6(3):458-462. doi: 10.1016/j.euf.2019.10.015. Epub 2019 Nov 6. Eur Urol Focus. 2020. PMID: 31704280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters